Page last updated: 2024-10-25

clobenpropit and Colorectal Neoplasms

clobenpropit has been researched along with Colorectal Neoplasms in 1 studies

clobenpropit: histamine H3 receptor antagonist
clobenpropit : An imidothiocarbamic ester that consists of isothiourea bearing S-3-(imidazol-4-yl)propyl and N-4-chlorobenzyl substituents. An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM.

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, Z1
Yao, W1
Xiong, Y1
Li, J1
Liu, L1
Shi, L1
Zhang, W1
Zhang, C1
Nie, L1
Wan, J1

Other Studies

1 other study available for clobenpropit and Colorectal Neoplasms

ArticleYear
Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression.
    BMC cancer, 2011, May-24, Volume: 11

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell

2011